HBIO CIK: 1123494

Harvard Bioscience Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.26
FY22:
1.15
FY23:
14.0
FY24:
1.44
FY25:
6.73
Change from FY21 to FY25
millions USD
FY21:
−1.35
FY22:
−1.59
FY23:
−1.80
FY24:
−1.34
FY25:
−1.86
Change from FY21 to FY25
millions USD
FY21:
−0.25
FY22:
−2.84
FY23:
−12.1
FY24:
−0.13
FY25:
−1.29
millions USD
FY21:
−0.50
FY22:
−3.31
FY23:
−0.23
FY24:
−0.18
FY25:
4.51
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.07
FY22:
−0.44
FY23:
12.2
FY24:
−1.20
FY25:
5.47

All amounts in millions USD Data source:SEC EDGAR